4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0001193125-26-001097
Chief Legal Officer sold 2,272 shares at $31.16 ($70,796)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tousignant Jennifer Chief Legal Officer | 2025-12-31 | Sale | −2,272 | $31.16 | $70,796 | 0 | D |
| Open-market sales · 2,272 sh · avg $31.16 · $70,796 | |||||||
Loading xslF345X05/ownership.xml…